Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Range Resources Corporation Common Stock (RRC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Range Resources Corporation Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Range Resources Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Range Resources Corporation Common Stock trades at $41.78 (market cap $9.93B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Range Resources Corporation Common Stock is far larger — about 5.5× Vir Biotechnology Inc. Common Stock's market cap, and Range Resources Corporation Common Stock pays a 0.94% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Range Resources Corporation Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

RRCVIR
Market Cap
$9.93B$1.80B
Volume
2,413,7521,782,836
Sector
EnergyHealth
52-Week High
$47.65$11.78
52-Week Low
$33.43$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.94B$1.36B
Dividend Yield
0.94%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Range Resources Corporation Common Stock

Range Resources (RRC) trades at $42.48, up 2.56% today, with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows solid fundamentals with a P/E of 11.73 and net income margin of 26.32%, while technical indicators signal neutral momentum near key resistance at $43. Recent institutional buying and positive analyst coverage (38.71% buy ratings) support the bullish case.

Outlook remains positive with Q3 2026 earnings expected at $0.776 per share and consensus price target of $44.00 offering 3.6% upside. Risks include energy price volatility and negative net cash flow of -$304M in 2025, though improved 2026 projections show operating cash flow growth to $1.4B.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RRC
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Range Resources Corporation Common Stock

Range Resources Corporation is an independent natural gas and natural gas liquids producer operating in the Appalachian Basin, primarily the Marcellus Shale in Pennsylvania, handling drilling, completion, and gathering and transportation connections for its production.

Read more on RRC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →